PMID- 35718709 OWN - NLM STAT- MEDLINE DCOM- 20220928 LR - 20231213 IS - 1440-1592 (Electronic) IS - 1323-8930 (Print) IS - 1323-8930 (Linking) VI - 71 IP - 4 DP - 2022 Oct TI - Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines. PG - 512-519 LID - S1323-8930(22)00048-X [pii] LID - 10.1016/j.alit.2022.05.007 [doi] AB - BACKGROUND: The mechanism of allergic reactions to COVID-19 mRNA vaccines has not been clarified. Polyethylene glycol (PEG) is a potential antigen in the components of vaccines. However, there is little evidence that allergy after COVID-19 mRNA vaccination is related to PEG. Furthermore, the role of polysorbate (PS) as an antigen has also not been clarified. The objective of this study was to investigate whether PEG and PS allergies are reasonable causes of allergic symptoms after vaccination by detecting PEG-specific and PS-specific antibodies. METHODS: Fourteen patients who developed immediate allergic reactions to BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccines and nineteen healthy controls who did not present allergic symptoms were recruited. Serum PEG-specific immunoglobulin E (IgE) and immunoglobulin G (IgG) and PS-specific IgE and IgG were measured by enzyme-linked immunosorbent assay. Skin tests using PEG-2000 and PS-80 were applied to five patients and three controls. RESULTS: Serum levels of PEG-specific IgE and IgG in patients with immediate allergic reactions to the COVID-19 mRNA vaccine were higher than those in the control group. Serum levels of PS-specific IgE in patients with allergy to the vaccine were higher than those in patients of the control group. Intradermal tests using PEG verified the results for PEG-specific IgE and IgG. CONCLUSIONS: The results suggest that PEG is one of the antigens in the allergy to COVID-19 mRNA vaccines. Cross-reactivity between PEG and PS might be crucial for allergy to the vaccines. PEG-specific IgE and IgG may be useful in diagnosing allergy to COVID-19 mRNA vaccines. CI - Copyright (c) 2022 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved. FAU - Mouri, Mariko AU - Mouri M AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan; Department of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. FAU - Imamura, Mitsuru AU - Imamura M AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. Electronic address: mitsuru.imamura@marianna-u.ac.jp. FAU - Suzuki, Shotaro AU - Suzuki S AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Kawasaki, Tatsuya AU - Kawasaki T AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Ishizaki, Yoshiki AU - Ishizaki Y AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Sakurai, Keiichi AU - Sakurai K AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Nagafuchi, Hiroko AU - Nagafuchi H AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Matsumura, Norihiro AU - Matsumura N AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Uchida, Marina AU - Uchida M AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Ando, Takayasu AU - Ando T AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Yoshioka, Kohei AU - Yoshioka K AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Ooka, Seido AU - Ooka S AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Sugihara, Takahiko AU - Sugihara T AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Miyoshi, Hiroshi AU - Miyoshi H AD - Department of Microbiology, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Mori, Masaaki AU - Mori M AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan; Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University, Tokyo, Japan; Livelong Care Center for Rheumatic Diseases, Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Okada, Tomoyuki AU - Okada T AD - Department of Otolaryngology and Health Service Center, St. Marianna University School of Medicine, Kawasaki, Japan. FAU - Yamaguchi, Masao AU - Yamaguchi M AD - Division of Respiratory Medicine, Third Department of Medicine, Teikyo University Chiba Medical Center, Chiba, Japan. FAU - Kunishima, Hiroyuki AU - Kunishima H AD - Department of Infectious Disease, St. Marianna University School of Medicine, Kanagawa, Japan. FAU - Kato, Motohiro AU - Kato M AD - Department of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. FAU - Kawahata, Kimito AU - Kawahata K AD - Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan. LA - eng PT - Journal Article DEP - 20220606 PL - England TA - Allergol Int JT - Allergology international : official journal of the Japanese Society of Allergology JID - 9616296 RN - 0 (COVID-19 Vaccines) RN - 0 (Immunoglobulin G) RN - 0 (Polysorbates) RN - 0 (RNA, Messenger) RN - 0 (Vaccines, Synthetic) RN - 0 (mRNA Vaccines) RN - 37341-29-0 (Immunoglobulin E) RN - 3WJQ0SDW1A (Polyethylene Glycols) RN - N38TVC63NU (BNT162 Vaccine) SB - IM MH - BNT162 Vaccine/*adverse effects MH - *COVID-19/diagnosis/prevention & control MH - COVID-19 Vaccines/adverse effects MH - Humans MH - *Hypersensitivity/diagnosis MH - Hypersensitivity, Immediate MH - Immunoglobulin E/blood MH - Immunoglobulin G/blood MH - Polyethylene Glycols MH - Polysorbates MH - RNA, Messenger MH - Vaccines, Synthetic MH - mRNA Vaccines PMC - PMC9167845 OTO - NOTNLM OT - COVID-19 mRNA vaccines OT - PEG-specific IgE OT - PEG-specific IgG OT - Polyethylene glycol OT - Polysorbate EDAT- 2022/06/20 06:00 MHDA- 2022/09/28 06:00 PMCR- 2022/06/06 CRDT- 2022/06/19 22:19 PHST- 2022/02/09 00:00 [received] PHST- 2022/05/02 00:00 [revised] PHST- 2022/05/10 00:00 [accepted] PHST- 2022/06/20 06:00 [pubmed] PHST- 2022/09/28 06:00 [medline] PHST- 2022/06/19 22:19 [entrez] PHST- 2022/06/06 00:00 [pmc-release] AID - S1323-8930(22)00048-X [pii] AID - 10.1016/j.alit.2022.05.007 [doi] PST - ppublish SO - Allergol Int. 2022 Oct;71(4):512-519. doi: 10.1016/j.alit.2022.05.007. Epub 2022 Jun 6.